Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2011

Open Access 01-12-2011 | Research

Phosphoproteomic analysis of apoptotic hematopoietic stem cells from hemoglobin E/β-thalassemia

Authors: Saranyoo Ponnikorn, Tasanee Panichakul, Kitima Sresanga, Chokdee Wongborisuth, Sittiruk Roytrakul, Suradej Hongeng, Sumalee Tungpradabkul

Published in: Journal of Translational Medicine | Issue 1/2011

Login to get access

Abstract

Background

Hemoglobin E/β-thalassemia is particularly common in Southeast Asia and has variable symptoms ranging from mild to severe anemia. Previous investigations demonstrated the remarkable symptoms of β-thalassemia in terms of the acceleration of apoptotic cell death. Ineffective erythropoiesis has been studied in human hematopoietic stem cells, however the distinct apoptotic mechanism was unclear.

Methods

The phosphoproteome of bone marrow HSCs/CD34+ cells from HbE/β-thalassemic patients was analyzed using IMAC phosphoprotein isolation followed by LC-MS/MS detection. Decyder MS software was used to quantitate differentially expressed proteins in 3 patients and 2 normal donors. The differentially expressed proteins from HSCs/CD34+ cells were compared with HbE/β-thalassemia and normal HSCs.

Results

A significant change in abundance of 229 phosphoproteins was demonstrated. Importantly, the analysis of the candidate proteins revealed a high abundance of proteins that are commonly found in apoptotic cells including cytochrome C, caspase 6 and apoptosis inducing factors. Moreover, in the HSCs patients a significant increase was observed in a specific type of phosphoserine/threonine binding protein, which is known to act as an important signal mediator for the regulation of cell survival and apoptosis in HbE/β-thalassemia.

Conclusions

Our study used a novel method to investigate proteins that influence a particular pathway in a given disease or physiological condition. Ultimately, phosphoproteome profiling in HbE/β-thalassemic stem cells is an effective method to further investigate the cell death mechanism of ineffective erythropoiesis in β-thalassemia. Our report provides a comprehensive phosphoproteome, an important resource for the study of ineffective erythropoiesis and developing therapies for HbE/β-thalassemia.
Appendix
Available only for authorised users
Literature
1.
Abetz L, Baladi JF, Jones P, Rofail D: The impact of iron overload and its treatment on quality of life: results from a literature review. Health Qual Life Outcomes. 2006, 4: 73-10.1186/1477-7525-4-73.PubMedCentralCrossRefPubMed
2.
3.
Premawardhena A, Fisher CA, Olivieri NF, de Silva S, Arambepola M, Perera W, O'Donnell A, Peto TE, Viprakasit V, Merson L, Muraga G, Weatherall DJ: Hemoglobin E beta thalassaemia in Sri Lanka. Lancet. 2005, 366: 1467-1470. 10.1016/S0140-6736(05)67396-5.CrossRefPubMed
4.
Winichagoon P, Fucharoen S, Chen P, Wasi P: Genetic factors affecting clinical severity in beta-thalassemia syndromes. J Pediatr Hematol Oncol. 2000, 22: 573-580. 10.1097/00043426-200011000-00026.CrossRefPubMed
5.
Yuan J, Angelucci E, Lucarelli G, Aljurf M, Snyder LM, Kiefer CR, Ma L, Schrier SL: Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe beta-thalassemia (Cooley's anemia). Blood. 1993, 82 (2): 374-377.PubMed
6.
Mathias LA, Fisher TC, Zeng L, Meiselman HJ, Weinberg KI, Hiti AL, Malik P: Ineffective erythropoiesis in beta-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage. Exp Hematol. 2000, 28 (12): 1343-1353. 10.1016/S0301-472X(00)00555-5.CrossRefPubMed
7.
Pootrakul P, Sirankapracha P, Hemsorach S, Moungsub W, Kumbunlue R, Piangitjagum A, Wasi P, Ma L, Schrier SL: A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia. Blood. 2000, 96 (7): 2606-2612.PubMed
8.
Kong Y, Zhou S, Kihm AJ, Katein AM, Yu X, Gell DA, Mackay JP, Adachi K, Foster-Brown L, Louden CS, Gow AJ, Weiss MJ: Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. J Clin Invest. 2004, 114 (10): 1457-1466.PubMedCentralCrossRefPubMed
9.
Choudhary C, Mann M: Decoding signalling networks by mass spectrometry-based proteomics. Nat Rev Mol Cell Biol. 2010, 11 (6): 427-439. 10.1038/nrm2900.CrossRefPubMed
10.
Mukherji M: Phosphoproteomics in analyzing signaling pathways. Expert Rev Proteomics. 2005, 2 (1): 117-128. 10.1586/14789450.2.1.117.CrossRefPubMed
11.
Macek B, Mann M, Olsen J: Global and Site-Specific Quantitative Phosphoproteomics: Principles and Applications. Annu Rev Pharmacol Toxicol. 2009, 49: 199-221. 10.1146/annurev.pharmtox.011008.145606.CrossRefPubMed
12.
Schmelzle K, White FM: Phosphoproteomic approaches to elucidate cellular signaling networks. Curr Opin Biotechnol. 2006, 17 (4): 406-414. 10.1016/j.copbio.2006.06.004.CrossRefPubMed
13.
Panichakul T, Sattabongkot J, Chotivanich K, Sirichaisinthop J, Cui L, Udomsangpetch R: Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax. Int J Parasitol. 2007, 37 (14): 1551-1557. 10.1016/j.ijpara.2007.05.009.CrossRefPubMed
14.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193 (1): 265-275.PubMed
15.
Johansson C, Samskog J, Sundström L, Wadensten H, Björkesten L, Flensburg J: Differential expression analysis of Escherichia coli proteins using a novel software for relative quantitation of LC-MS/MS data. Proteomics. 2006, 6 (16): 4475-4485. 10.1002/pmic.200500921.CrossRefPubMed
16.
Perkins DN, Pappin DJ, Creasy DM, Cottrell JS: Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999, 20 (18): 3551-3567. 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2.CrossRefPubMed
17.
Blom N, Gammeltoft S, Brunak S: Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol. 1999, 294 (5): 1351-1362. 10.1006/jmbi.1999.3310.CrossRefPubMed
18.
Carrascal M, Ovelleiro D, Casas V, Gay M, Abian J: Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment. J Proteome Res. 2008, 7 (12): 5167-5176. 10.1021/pr800500r.CrossRefPubMed
19.
Ge F, Xiao CL, Yin XF, Lu C, Zeng H, He QY: Phosphoproteomic analysis of primary human multiple myeloma cells. J Proteomics. 2010, 73 (7): 1381-1390. 10.1016/j.jprot.2010.03.004.CrossRefPubMed
20.
Schulze W, Usadel B: Quantitation in Mass-Spectrometry-Based Proteomics. Annu Rev Plant Biol. 2010, 61: 491-516. 10.1146/annurev-arplant-042809-112132.CrossRefPubMed
21.
22.
Rund D, Rachmilewitz E: Beta-thalassemia. N Engl J Med. 2005, 353 (11): 1135-1146. 10.1056/NEJMra050436.CrossRefPubMed
23.
Lithanatudom P, Leecharoenkiat A, Wannatung T, Svasti S, Fucharoen S, Smith DR: A mechanism of ineffective erythropoiesis in beta-thalassemia/Hb E disease. Haematologica. 2010, 95 (5): 716-723. 10.3324/haematol.2009.015701.PubMedCentralCrossRefPubMed
24.
Centis F, Tabellini L, Lucarelli G, Buffi O, Tonucci P, Persini B, Annibali M, Emiliani R, Iliescu A, Rapa S, Rossi R, Ma L, Angelucci M, Schrier SL: The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major. Blood. 2000, 96 (10): 3624-3629.PubMed
25.
Libani I, Guy E, Melchiori L, Schiro R, Ramos P, Breda L, Scholzen T, Chadburn A, Liu Y, Kernbach M, Baron-Luhr B, Porotto M, Sousa M, Rachmilewitz EA, Hood JD, Cappellini D, Giardina PJ, Grady RW, Gerdes J, Rivella S: Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia. Blood. 2008, 112 (3): 875-885. 10.1182/blood-2007-12-126938.PubMedCentralCrossRefPubMed
26.
Harris MH, Thompson CB: The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death and Differentiation. 2000, 7 (12): 1182-1191. 10.1038/sj.cdd.4400781.CrossRefPubMed
27.
Opferman JT, Korsmeyer SJ: Apoptosis in the development and maintenance of the immune system. Nat Immunol. 2003, 4 (5): 410-415. 10.1038/ni0503-410.CrossRefPubMed
28.
Ow Y, Green DR, Hao Z, Mak T: Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol. 2008, 9 (7): 532-542. 10.1038/nrm2434.CrossRefPubMed
29.
Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G: Mechanisms of cytochrome c release from mitochondria. Cell Death and Differentiation. 2006, 13 (9): 1423-1433. 10.1038/sj.cdd.4401950.CrossRefPubMed
30.
Gogvadze V, Orrenius S, Zhivotovsky B: Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim Biophys Acta. 2006, 1757 (5-6): 639-647. 10.1016/j.bbabio.2006.03.016.CrossRefPubMed
31.
De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, Pelosi E, Riccioni R, Felli N, Samoggia P, Peschle C: Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood. 1999, 93 (3): 796-803.PubMed
32.
Schrier SL, Centis F, Verneris M, Ma L, Angelucci E: The role of oxidant injury in the pathophysiology of human thalassemias. Redox report: communications in free radical research. 2003, 8 (5): 241-245.CrossRefPubMed
33.
Wiley SR, Winkles JA: TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev. 2003, 14 (3-4): 241-249. 10.1016/S1359-6101(03)00019-4.CrossRefPubMed
34.
Han S, Yoon K, Lee K, Kim K, Jang H, Lee NK, Hwang K, Young Lee S: TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors. Biochemical and biophysical research communications. 2003, 305 (4): 789-796. 10.1016/S0006-291X(03)00852-0.CrossRefPubMed
35.
Inoue S, Browne G, Melino G, Cohen GM: Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death and Differentiation. 2009, 16 (7): 1053-1061. 10.1038/cdd.2009.29.CrossRefPubMed
36.
Ruchaud S, Korfali N, Villa P, Kottke TJ, Dingwall C, Kaufmann SH, Earnshaw WC: Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO J. 2002, 21 (8): 1967-1977. 10.1093/emboj/21.8.1967.PubMedCentralCrossRefPubMed
37.
Friedman JR, Kaestner KH: The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci. 2006, 63 (19-20): 2317-2328. 10.1007/s00018-006-6095-6.CrossRefPubMed
38.
Song L, Wei X, Zhang B, Luo X, Liu J, Feng Y, Xiao X: Role of Foxa1 in regulation of bcl2 expression during oxidative-stress-induced apoptosis in A549 type II pneumocytes. Cell Stress and Chaperones. 2009, 14 (4): 417-425. 10.1007/s12192-008-0095-4.PubMedCentralCrossRefPubMed
39.
Maceyka M, Payne SG, Milstien S, Spiegel S: Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta. 2002, 1585 (2-3): 193-201.CrossRefPubMed
40.
Reiss U, Oskouian B, Zhou J, Gupta V, Sooriyakumaran P, Kelly S, Wang E, Merrill AH, Saba JD: Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis. J Biol Chem. 2004, 279 (2): 1281-1290. 10.1074/jbc.M309646200.CrossRefPubMed
41.
Meerang M, Nair J, Sirankapracha P, Thephinlap C, Srichairatanakool S, Arab K, Kalpravidh R, Vadolas J, Fucharoen S, Bartsch H: Accumulation of lipid peroxidation-derived DNA lesions in iron-overloaded thalassemic mouse livers: Comparison with levels in the lymphocytes of thalassemia patients. Int J Cancer. 2009, 125 (4): 759-766. 10.1002/ijc.24412.CrossRefPubMed
42.
Meerang M, Nair J, Sirankapracha P, Thephinlap C, Srichairatanakool S, Fucharoen S, Bartsch H: Increased urinary 1, N6-ethenodeoxyadenosine and 3, N4-ethenodeoxycytidine excretion in thalassemia patients: markers for lipid peroxidation-induced DNA damage. Free Radic Biol Med. 2008, 44 (10): 1863-1868. 10.1016/j.freeradbiomed.2008.02.009.CrossRefPubMed
43.
Wannatung T, Lithanatudom P, Leecharoenkiat A, Svasti S, Fucharoen S, Smith DR: Increased erythropoiesis of β-thalassaemia/Hb E proerythroblasts is mediated by high basal levels of ERK1/2 activation. British Journal of Haematology. 2009, 146 (5): 557-568. 10.1111/j.1365-2141.2009.07794.x.CrossRefPubMed
44.
Tzivion G, Avruch J: 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem. 2002, 277 (5): 3061-3064. 10.1074/jbc.R100059200.CrossRefPubMed
45.
Muslin AJ, Xing H: 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal. 2000, 12 (11-12): 703-709. 10.1016/S0898-6568(00)00131-5.CrossRefPubMed
46.
Yang J, Hung M: A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer. Clinical Cancer Research. 2009, 15 (3): 752-757. 10.1158/1078-0432.CCR-08-0124.PubMedCentralCrossRefPubMed
47.
Huang H, Tindall DJ: Dynamic FoxO transcription factors. J Cell Sci. 2007, 120 (15): 2479-2487. 10.1242/jcs.001222.CrossRefPubMed
48.
Tsuruta F, Sunayama J, Mori Y, Hattori S, Shimizu S, Tsujimoto Y, Yoshioka K, Masuyama N, Gotoh Y: JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J. 2004, 23 (8): 1889-1899. 10.1038/sj.emboj.7600194.PubMedCentralCrossRefPubMed
49.
Yoshida K, Yamaguchi T, Natsume T, Kufe D, Miki Y: JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat Cell Biol. 2005, 7 (3): 278-285. 10.1038/ncb1228.CrossRefPubMed
50.
Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, Burgering BM: FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 2004, 23 (24): 4802-4812. 10.1038/sj.emboj.7600476.PubMedCentralCrossRefPubMed
51.
Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ: Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol. 2000, 10 (19): 1201-1204. 10.1016/S0960-9822(00)00728-4.CrossRefPubMed
52.
Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM, Medema RH: The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol. 2002, 168 (10): 5024-5031.CrossRefPubMed
53.
Modur V, Nagarajan R, Evers BM, Milbrandt J: FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem. 2002, 277 (49): 47928-47937. 10.1074/jbc.M207509200.CrossRefPubMed
54.
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999, 96 (6): 857-868. 10.1016/S0092-8674(00)80595-4.CrossRefPubMed
55.
Hütter G, Letsch A, Nowak D, Poland J, Sinha P, Thiel E, Hofmann WK: High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia. J Transl Med. 2009, 7: 7-10.1186/1479-5876-7-7.PubMedCentralCrossRefPubMed
56.
Ge F, Li WL, Bi LJ, Tao SC, Zhang ZP, Zhang XE: Identification of Novel 14-3-3zeta Interacting Proteins by Quantitative Immunoprecipitation Combined with Knockdown (QUICK). J Proteome Res. 2010, 9 (11): 5848-5858. 10.1021/pr100616g.CrossRefPubMed
Metadata
Title
Phosphoproteomic analysis of apoptotic hematopoietic stem cells from hemoglobin E/β-thalassemia
Authors
Saranyoo Ponnikorn
Tasanee Panichakul
Kitima Sresanga
Chokdee Wongborisuth
Sittiruk Roytrakul
Suradej Hongeng
Sumalee Tungpradabkul
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2011
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-9-96

Other articles of this Issue 1/2011

Journal of Translational Medicine 1/2011 Go to the issue

Research

Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments

Research

Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke

Research

Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer

Review

Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome

Research

Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines

Review

Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits